Aligos Therapeutics (ALGS)
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
Alto Ingredients Inc (ALTO)
Alto Ingredients, Inc. Reports Second Quarter 2025 Results
Arcus Biosciences Inc. (RCUS)
Arcus Biosciences - Arcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline Update
Exact Sciences Corporation (EXAS)
Exact Sciences Announces Exclusive License with Freenome for Blood-Based Colorectal Cancer Screening Tests
KORU Medical Systems Inc (KRMD)
KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance
Schrodinger Inc (SDGR)
Schrödinger, Inc. - Schrödinger Reports Second Quarter 2025 Financial Results
Avita Medical Ltd (RCEL)
AVITA Medical Announces Appointment of Michael Tarnoff, MD, FACS, to its Board of Directors and Transition of Board Chair Role to Cary Vance
Vir Biotechnology (VIR)
Vir Biotechnology - Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2025 Financial Results
OmniAb Inc (OABI)
OmniAb - OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights
OmniAb Inc (OABIW)
OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights
Sera Prognostics Inc (SERA)
SERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
Arcus Biosciences Inc. (RCUS)
Arcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline Update
Veeva Systems Inc (VEEV)
Veeva to Release Fiscal 2026 Second Quarter Results on August 27, 2025
Cardio Diagnostics Holdings Inc (CDIOW)
Veeva to Release Fiscal 2026 Second Quarter Results on August 27, 2025
Procept Biorobotics Corp (PRCT)
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance